Skip to main content
CBRS
NASDAQ Manufacturing

Director Lior Susan & Eclipse Funds Disclose 6.1% Stake with High Voting Power Post-IPO

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
7
Price
$254.83
Mkt Cap
$56.392B
52W Low
$250.27
52W High
$386.34
Market data snapshot near publication time

summarizeSummary

Director Lior Susan and associated Eclipse funds have filed an initial Schedule 13D, disclosing a 6.1% beneficial ownership stake in Cerebras Systems, primarily through high-voting Class B common stock, following the company's IPO.


check_boxKey Events

  • Significant Beneficial Ownership Disclosed

    Director Lior Susan and affiliated Eclipse funds report beneficial ownership of 13,466,197 shares of Class B common stock in Cerebras Systems.

  • Substantial Voting Power

    These Class B shares represent 6.1% of the total outstanding common stock and carry 20 votes per share, granting the reporting persons significant voting control.

  • Post-IPO Initial Disclosure

    This Schedule 13D is an initial filing following the company's IPO on May 15, 2026, reflecting the automatic conversion of preferred stock into Class B common stock upon closing.

  • Subject to Lock-up Agreement

    The reporting persons are subject to a 180-day lock-up period, restricting sales of these shares following the IPO.


auto_awesomeAnalysis

This Schedule 13D filing establishes the beneficial ownership structure of Cerebras Systems following its recent IPO. Director Lior Susan and affiliated Eclipse funds collectively hold a significant 6.1% stake in the company, primarily through Class B common stock. These Class B shares carry 20 votes per share, granting the reporting persons substantial voting control over the company. This disclosure is important for understanding the distribution of power and influence within the newly public company.

At the time of this filing, CBRS was trading at $254.83 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $56.4B. The 52-week trading range was $250.27 to $386.34. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CBRS - Latest Insights

CBRS
May 22, 2026, 4:28 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
CBRS
May 15, 2026, 4:23 PM EDT
Filing Type: 8-K
Importance Score:
8
CBRS
May 15, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
CBRS
May 14, 2026, 5:15 PM EDT
Filing Type: 424B4
Importance Score:
9
CBRS
May 13, 2026, 7:46 PM EDT
Source: Dow Jones Newswires
Importance Score:
9